Evommune, Inc.
EVMN
$14.65
$0.584.12%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -137.71% | -48.89% | -36.41% | 21.62% | 50.46% |
| Total Depreciation and Amortization | 47.20% | -7.43% | -9.44% | -6.04% | 15.38% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 143.93% | 990.98% | 7,422.92% | -36.36% | -14,004.84% |
| Change in Net Operating Assets | 276.36% | 11.27% | 322.87% | 123.14% | -123.11% |
| Cash from Operations | 22.48% | -15.08% | 9.79% | 63.26% | -203.83% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 74.87% | -731.67% | -271.21% | -352.60% | 79.19% |
| Cash from Investing | 73.86% | -732.29% | -271.53% | -353.99% | 79.52% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 8.39% | 43.51% | 38.13% | -19.30% | -43.52% |
| Issuance of Common Stock | 16,750.00% | 5,859,800.00% | 1,429,754.55% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -100.00% | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -99.17% | 77,146.71% | 215.58% | -140.35% | 59,675.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -79.50% | 140.27% | 1,012.11% | -99.75% | 4,241.30% |